Adiponectin: A new link between obesity, insulin resistance and cardiovascular disease;Adiponectina: Un nuevo nexo entre obesidad, resistencia a la insulina y enfermedad cardiovascular

Medicina Clinica

Volumn 124, Issue 10, 2005, Pages 388-395

  Palomer, Xavier ^a   Pérez, Antonio ^a,b   Blanco Vaca, Francisco ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Adiponectin; Atherosclerosis; Insulin resistance; Obesity; Type 2 diabetes

Indexed keywords

ADIPONECTIN; ANTIOBESITY AGENT; CELL ADHESION MOLECULE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANTIINFLAMMATORY ACTIVITY; ATHEROGENESIS; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; FATTY ACID OXIDATION; FOAM CELL; GLUCOSE METABOLISM; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; MACROPHAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; REVIEW; SMOOTH MUSCLE FIBER;

EID: 17144392614     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13072576     Document Type: Review

References (58)

1. Arner P. The adipocyte in insulin resistance? key molecules and the impact of the thiazolidinediones. Trends Endocrinol Metab 2003;14:137-45.
2. Beltowski J. Adiponectin and resistin - new hormones of white adipose tissue. Med Sci Monit 2003;9:55RA-61.
3. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 2003;14:561-6.
4. Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin: more than just another fat cell hormone? Diabetes Care 2003;26:2442-50.
5. Phillips SA, Ciaraldi TP, Kong APS, Bandukwala R, Aroda V, Carter L, et al. Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy. Diabetes 2003;52:667-74.
6. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (Adipose Most abundant Gene transcript 1). Biochem Biophys Res Commun 1996;221:286-9.
7. Nakano Y, Tobe T, Choi-Miura NH, Mazda T, Tomita T. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem 1996;20:803-12.
8. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995;270:26746-9.
9. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996;271:10697-703.
10. Wang Y, Xu A, Knight C, Xu LX, Cooper GJS. Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin. J Biol Chem 2002;277:19521-9.
11. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 2001;98:2005-10.
12. Tsao TS, Murrey HE, Hug C, Lee DH, Lodish HF. Oligomerization state-dependent activation of NF-kB signalling pathway by adipocyte complement-related protein of 30 kDa (Acrp30). J Biol Chem 2002;277:29359-62.
13. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83.
14. Snehalatha C, Mukesh B, Simon M, Viswanathan V, Haffner SM, Ramachandran A. Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians. Diabetes Care 2003;26:3226-9.
15. Hanley AJG, Connelly PW, Harris SB, Zinman B. Adiponectin in a native Canadian population experiencing rapid epidemiological transition. Diabetes Care 2003;26:3219-25.
16. Moore GB, Chapman H, Holder JC, Lister CA, Piercy V, Smith SA, et al. Differential regulation of adipocytokine mRNAs by rosglitazone in db/db mice. Biochem Biophys Res Comun 2001;286:735-41.
17. Yamauchi T, Kamon J, Kaki H, Terauchi Y, Kubota N, Hara K, et al. The fat-derived hormone Adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941-6.
18. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003;423:762-9.
19. Kharroubi I, Rasschaert J, Eizirik DL, Cnop M. Expression of adiponectin receptors in pancreatic âcells. Biochem Biophys Res Commun 2003;312:1118-22.
20. Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, Hansen BC, et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001;50:1126-33.
21. Yatagai T, Nagasaka S, Taniguchi A, Fukushima M, Nakamura T, Kuroe A, et al. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 2003;52:1274-8.
22. Comuzzie AG, Funahashi T, Sonnenberg G, Martin U, Jacob HJ, Black AE, et al. The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metab 2001;86:4321-5.
23. Havel PJ. Update on adipocyte hormones. Regulation of energy balance and carbohvdrate/lioid metabolism. Diabetes 2004;53:5143-51.
24. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentration of a novel adipose specific protein adiponectin in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000;20:1595-9.
25. y/a) obese mice. Diabetes 2003;52:2266-73.
26. Sánchez-Recalde Á, Kaski JC. Diabetes mellitus, inflamación y aterosclerosis coronaria: perspectiva actual y futura. Rev Esp Cardiol 2001;54:751-63.
27. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, et al. Adiponectin and development of type 2 diabetes in the PIMA Indian population. Lancet Res Lett 2002;360:57-8.
28. Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, Boeing H, et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet Res Lett 2003;361:226-8.
29. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-5.
30. Retnakaran R, Hanley AJG, Raif N, Connelly PW, Sermer M, Zinman B. Reduced adiponectin concentration in women with gestational diabetes. Diabetes Care 2004;27:799-800.
31. Stefan N, Stumvoll M, Vozarova B, Weyer C, Funahashi T, Matsuzawa Y, et al. Plasma adiponectin and endogenous glucose production in humans. Diabetes Care 2003;26:3315-9.
32. Imagawa A, Funahashi T, Nakamura T, Noriwaki M, Tanaka S, Hishizawa H, et al. Elevated serum concentration of adipose-derived factor, adiponectin, in patients with type 1 diabetes. Diabetes Care 2002;25:1665-6.
33. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, et al. Diet-induced insulin resistance in mice lacking adiponectin/ ACRP30. Nat Med 2002;8:731-7.
34. Bogan JS, Lodish HF. Two compartments for insulin-stimulated exocytosis in 3T3-L1 adipocytes defined by endogenous ACRP30 and GLUT4. J Cell Biol 1999;146:609-20.
35. Smith U, Axelsen M, Carvalho E, Eliasson B, Jansson PA, Wesslau C. Insulin signalling and action in fat cells: associations with insulin resistance and type 2 diabetes. Ann NY Acad Sci 1999;892:119-26.
36. Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K, et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002;51:536-40.
37. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004;24:29-33.
38. Stumvoll M, Tschritter O, Pritsche A, Staiger H, Renn W, Weisser M, et al. Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. Diabetes 2002;51:37-41.
39. Goldfine AB, Kahn CR. Adiponectin: linking the fat cell to insulin sensitivity. Lancet 2003;362:1431-2.
40. Hu FB, Doria A, Li T, Meigs JB, Liu S, Memisoglu A. Genetic variation at the adiponectin locus and risk of type 2 diabetes in women. Diabetes 2004;53:209-13.
41. Díez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003;148:293-300.
42. Boden G, Shulman Gl. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β-cell dysfunction. Eur J Clin Invest 2002;32:14-23.
43. Moller DE. New drug targets for type 2 diabetes and the metabolic syndrome. Nature 2001;414:821-7.
44. Chinetti G, Zawadski C, Fruchart JC, Staelos B. Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARα, PPARγ, and LXR. Biochem Biophys Res Commun 2004;314:151-8.
45. Shimada K, Miyazaki T, Daida H. Adiponectin and atherosclerotic disease. Clin Chim Acta 2004;344:1-12.
46. Kappes A, Loffler G. Influences of ionomycin, dibutyryl-cycloAMP and tumour necrosis factor alpha on intracellular amount and secretion of apM1 in differentiating primary human preadipocytes. Hormone Metab Res 2000;32:548-54.
47. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999;100:2473-6.
48. Motoshima H, Wu X, Mahadev K, Goldstein BJ. Adiponectin suppresses proliferation and Superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL. Biochem Biophys Res Commun 2004;315:264-71.
49. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappa B signalling through cAMP-dependent pathway. Circulation 2000;102:1296-301.
50. Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Cir Res 2001;89:763-71.
51. Krakoff J, Funahashi T, Stehouwer CD, Schalkwijk CJ, Tanaka S, Matsuzawa Y, et al. Inflammatory markers, adiponectin, and risk of type 2 diabetes in the PIMA Indian. Diabetes Care 2003;26:1745-51.
52. Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher M, Klein J, et al. Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2003;301:1045-50.
53. Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000;96:1723-32.
54. Arita Y, Kihara S, Ouchi N, Maeda K, Kuriyama H, Okamoto Y, et al. Adipocyte-derived plasma protein, adiponectin, acts as a platelet-derived growth factor-BB binding protein, and regulates growth factor-induced common post-receptor signal in vascular smooth muscle cell. Circulation 2002;105:2893-8.
55. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001;103:1057-63.
56. Esposito K, Nappo F, Giugliano F, Di Palo C, Ciotola M, Barbieri M, et al. Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus. Am J Clin Nut 2003;78:1135-40.
57. Esposito K, Pontillo A, Ciotola M, Di Palo C, Grella E, Nicoletti G, et al. Weight loss reduces interleukin-18 levels in obese women. J Clin Endocrinol Metab 2002;87:3864-6.
58. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001;7:947-53.